Can oral fluid testing be used to replace blood-based HIV rapid testing to scale up access to diagnosis and treatment in cameroon?

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 4, 2011, Pages

  Ndembi, Nicaise ^a,b,c   Ngansop, Charlotte ^a   Moudourou, Sylvie ^d   Tagny, Claude Tayou ^a,d   Abimiku, Alash'Le ^b   Mbanya, Dora Shu ^a,d   Kaptue, Lazare Noche ^a,e  

^a UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF HUMAN VIROLOGY NIGERIA   (Nigeria)

^d Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

^e Higher Institute of Public Health Sciences   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY RESPONSE; BLOOD EXAMINATION; BODY FLUID; CAMEROON; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; FALSE NEGATIVE RESULT; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; INTERMETHOD COMPARISON; LETTER; ORAL FLUID TEST; PANDEMIC; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SEROLOGY;

BLOOD; CAMEROON; CROSS-SECTIONAL STUDIES; EXUDATES AND TRANSUDATES; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MOUTH MUCOSA; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VIROLOGY;

EID: 79952382869     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31820a9d1d     Document Type: Letter

References (8)

1. Scott L, Noble L, Langeveldt M, et al. Can oral fluid testing be used to replace blood based HIV rapid testing to improve access to diagnosis in South Africa? J Acquir Immune Defic Syndr. 2009;51:646-647.
2. Hamers R, de Beer I, Kaura H, et al. Diagnostic accuracy of two oral fluid based tests for HIV surveillance in Namibia. J Acquir Immune Defic Syndr. 2008;48:116-118. (Pubitemid 351600849)
3. Plantier JC, Leoz M, Dickerson JE, et al. A new Human immunodeficiency virus derived from Gorillas. Nat Med. 2009;15:871-872.
4. Aghokeng AF, Mpoudi-Ngole E, Dimodi H, et al. Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon. PLoS One. 2009;4:e7702.
5. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
6. Ndembi N, Abraha A, Pilch H, et al. Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol. 2008;46:177-184.
7. Oral P, Svennerholm B, Jeansson S, et al. Continuous epitopes of the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein and reactivity of human sera to synthetic peptides representing various HIV-1 isolates. J Virol. 1991;65: 2718-2723.
8. Kagulire SC, Stamper PD, Opendi P, et al. Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodefi- ciency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda). Clin Vaccine Immunol. 2007; 14:738-740. (Pubitemid 47104762)